|
1
|
Mallok A, Vaillant JD, Soto MT,
Viebahn-Hänsler R, Viart ML, Pérez AF, Cedeño RI and Fernández OS:
Ozone protective effects against PTZ-induced generalized seizures
are mediated by reestablishment of cellular redox balance and A1
adenosine receptors. Neurol Res. 37:204–210. 2015.PubMed/NCBI
|
|
2
|
Lawson T and Yeager S: Status epilepticus
in adults: A review of diagnosis and treatment. Crit Care Nurse.
36:62–73. 2016.PubMed/NCBI
|
|
3
|
Sutter R, Semmlack S and Kaplan PW:
Nonconvulsive status epilepticus in adults - insights into the
invisible. Nat Rev Neurol. 12:281–293. 2016.PubMed/NCBI
|
|
4
|
Córdova-Dávalos L, Carrera-Calvo D,
Solís-Navarrete J, Mercado-Gómez OF, Arriaga-Ávila V,
Agredano-Moreno LT, Jiménez-García LF and Guevara-Guzmán R: Status
epilepticus triggers early mitochondrial fusion in the rat
hippocampus in a lithium-pilocarpine model. Epilepsy Res.
123:11–19. 2016.PubMed/NCBI
|
|
5
|
Cui Y, Liu J, Luo Y, He S, Xia Y, Zhang Y,
Yao D and Guo D: Aberrant connectivity during pilocarpine-induced
status epilepticus. Int J Neural Syst. 30:19500292020.PubMed/NCBI
|
|
6
|
Xie L, Li T, Song X, Sun H, Liu J, Yang J,
Zhao W, Cheng L, Chen H, Liu B, et al: Dynamic alteration of
dendrites and dendritic spines in the hippocampus and microglia in
mouse brain tissues after kainate-induced status epilepticus. Int J
Neurosci. Jun 1–2020.(Epub ahead of print).
|
|
7
|
Hu JH, Malloy C and Hoffman DA: P38
Regulates kainic acid-induced seizure and neuronal firing via Kv4.2
phosphorylation. Int J Mol Sci. 21:E59212020.PubMed/NCBI
|
|
8
|
Che Y, Yu YM, Han PL and Lee JK: Delayed
induction of p38 MAPKs in reactive astrocytes in the brain of mice
after KA-induced seizure. Brain Res Mol Brain Res. 94:157–165.
2001.PubMed/NCBI
|
|
9
|
Neligan A and Shorvon SD: Frequency and
prognosis of convulsive status epilepticus of different causes: A
systematic review. Arch Neurol. 67:931–940. 2010.PubMed/NCBI
|
|
10
|
Matute C and Cavaliere F: Neuroglial
interactions mediated by purinergic signalling in the
pathophysiology of CNS disorder. Semin Cell Dev Biol. 22:252–259.
2011.PubMed/NCBI
|
|
11
|
Li T, Quan Lan J, Fredholm BB, Simon RP
and Boison D: Adenosine dysfunction in astrogliosis: Cause for
seizure generation? Neuron Glia Biol. 3:353–366. 2007.PubMed/NCBI
|
|
12
|
Masino SA, Kawamura M Jr and Ruskin DN:
Adenosine receptors and epilepsy: Current evidence and future
potential. Int Rev Neurobiol. 119:233–255. 2014.PubMed/NCBI
|
|
13
|
Boison D: Adenosine dysfunction in
epilepsy. Glia. 60:1234–1243. 2012.PubMed/NCBI
|
|
14
|
Cunha RA: How does adenosine control
neuronal dysfunction and neurodegeneration. J Neurochem.
2016.139(6). 1019–1055. PubMed/NCBI
|
|
15
|
Hargus NJ, Jennings C, Perez-Reyes E,
Bertram EH and Patel MK: Enhanced actions of adenosine in medial
entorhinal cortex layer II stellate neurons in temporal lobe
epilepsy are mediated via A(1)-receptor activation. Epilepsia.
53:168–176. 2012.PubMed/NCBI
|
|
16
|
Ono K and Han J: The p38 signal
transduction pathway: Activation and function. Cell Signal.
12:1–13. 2000.PubMed/NCBI
|
|
17
|
Downey JS and Han J: Cellular activation
mechanisms in septic shock. Front Biosci. 3:d468–d476.
1998.PubMed/NCBI
|
|
18
|
Robinson MJ and Cobb MH: Mitogen-activated
protein kinase pathways. Curr Opin Cell Biol. 9:180–186.
1997.PubMed/NCBI
|
|
19
|
Okamoto OK, Janjoppi L, Bonone FM, Pansani
AP, da Silva AV, Scorza FA and Cavalheiro EA: Whole transcriptome
analysis of the hippocampus: Toward a molecular portrait of
epileptogenesis. BMC Genomics. 11:2302010.PubMed/NCBI
|
|
20
|
Yang Z, Wang J, Yu C, Xu P, Zhang J, Peng
Y, Luo Z, Huang H, Zeng J and Xu Z: Inhibition of p38 MAPK
signaling regulates the expression of EAAT2 in the brains of
epileptic rats. Front Neurol. 9:9252018.PubMed/NCBI
|
|
21
|
Minor TR, Rowe M, Cullen PK and Furst S:
Enhancing brain adenosine signaling with the nucleoside transport
blocker NBTI (S-(4-nitrobenzyl)-6-theoinosine) mimics the effects
of inescapable shock on later shuttle-escape performance in rats.
Behav Neurosci. 122:1236–1247. 2008.PubMed/NCBI
|
|
22
|
Huang H, Wang J, Zhang J, Luo Z, Li D, Qiu
X, Peng Y and Xu Z, Xu P and Xu Z: Nitrobenzylthioinosine mimics
adenosine to attenuate the epileptiform discharge of hippocampal
neurons from epileptic rats. Oncotarget. 8:35573–35582.
2017.PubMed/NCBI
|
|
23
|
Boison D: Adenosine as a modulator of
brain activity. Drug News Perspect. 20:607–611. 2007.PubMed/NCBI
|
|
24
|
Huang M, Wang Y, Collins M, Gu JJ,
Mitchell BS and Graves LM: Inhibition of nucleoside transport by
p38 MAPK inhibitors. J Biol Chem. 277:28364–28367. 2002.PubMed/NCBI
|
|
25
|
Rashid K, Van der Zee CE, Ross GM, Chapman
CA, Stanisz J, Riopelle RJ, Racine RJ and Fahnestock M: A nerve
growth factor peptide retards seizure development and inhibits
neuronal sprouting in a rat model of epilepsy. Proc Natl Acad Sci
USA. 92:9495–9499. 1995.PubMed/NCBI
|
|
26
|
Bulavin DV, Phillips C, Nannenga B,
Timofeev O, Donehower LA, Anderson CW, Appella E and Fornace AJ Jr:
Inactivation of the Wip1 phosphatase inhibits mammary tumorigenesis
through p38 MAPK-mediated activation of the p16(Ink4a)-p19(Arf)
pathway. Nat Genet. 36:343–350. 2004.PubMed/NCBI
|
|
27
|
Li Q, Liu H, Du J, Chen B, Li Q, Guo X,
Huang X and Huang Q: Advanced glycation end products induce moesin
phosphorylation in murine brain endothelium. Brain Res. 1373:1–10.
2011.PubMed/NCBI
|
|
28
|
Mannangatti P, NarasimhaNaidu K, Damaj MI,
Ramamoorthy S and Jayanthi LD: A Role for p38 Mitogen-activated
Protein Kinase-mediated Threonine 30-dependent Norepinephrine
Transporter Regulation in Cocaine Sensitization and Conditioned
Place Preference. J Biol Chem. 290:10814–10827. 2015.PubMed/NCBI
|
|
29
|
Xu Z, Xu P, Chen Y, Liu J, Zhang Y, Lv Y,
Luo J, Fang M, Zhang J, Wang J, et al: ENT1 inhibition attenuates
epileptic seizure severity via regulation of glutamatergic
neurotransmission. Neuromolecular Med. 17:1–11. 2015.PubMed/NCBI
|
|
30
|
Marawar R, Basha M, Mahulikar A, Desai A,
Suchdev K and Shah A: Updates in refractory status epilepticus.
Crit Care Res Pract. 2018:97689492018.PubMed/NCBI
|
|
31
|
Smith PE: Management of Established Status
Epilepticus. N Engl J Med. 381:2171–2172. 2019.PubMed/NCBI
|
|
32
|
Terrone G, Frigerio F, Balosso S, Ravizza
T and Vezzani A: Inflammation and reactive oxygen species in status
epilepticus: Biomarkers and implications for therapy. Epilepsy
Behav. 101((Pt B)): 1062752019.PubMed/NCBI
|
|
33
|
Thijs RD, Surges R, O'Brien TJ and Sander
JW: Epilepsy in adults. Lancet. 393:689–701. 2019.PubMed/NCBI
|
|
34
|
Goodrich GS, Kabakov AY, Hameed MQ, Dhamne
SC, Rosenberg PA and Rotenberg A: Ceftriaxone treatment after
traumatic brain injury restores expression of the glutamate
transporter, GLT-1, reduces regional gliosis, and reduces
post-traumatic seizures in the rat. J Neurotrauma. 30:1434–1441.
2013.PubMed/NCBI
|
|
35
|
Wagner RG, Bottomley C, Ngugi AK, Ibinda
F, Gómez-Olivé FX, Kahn K, Tollman S, Newton CR, Wagner R, Twine R,
et al SEEDS Writing Group, : Incidence, remission and mortality of
convulsive epilepsy in rural northeast South Africa. PLoS One.
10:e01290972015.PubMed/NCBI
|
|
36
|
Arnold Cenobamate S.: new hope for
treatment-resistant epilepsy. Lancet Neurol. 19:23–24.
2020.PubMed/NCBI
|
|
37
|
Boison D: The Biochemistry and Epigenetics
of Epilepsy: Focus on Adenosine and Glycine. Front Mol Neurosci.
9:262016.PubMed/NCBI
|
|
38
|
Kwan P and Brodie MJ: Early identification
of refractory epilepsy. N Engl J Med. 342:314–319. 2000.PubMed/NCBI
|
|
39
|
Shao Y, Wang C, Hong Z and Chen Y:
Inhibition of p38 mitogen-activated protein kinase signaling
reduces multidrug transporter activity and anti-epileptic drug
resistance in refractory epileptic rats. J Neurochem.
136:1096–1105. 2016.PubMed/NCBI
|
|
40
|
Świąder MJ, Kotowski J and Łuszczki JJ:
Modulation of adenosinergic system and its application for the
treatment of epilepsy. Pharmacol Rep. 66:335–342. 2014.PubMed/NCBI
|
|
41
|
Sebastião AM and Ribeiro JA: Adenosine
receptors and the central nervous system. Handb Exp Pharmacol.
193:471–534. 2009.
|
|
42
|
Fredholm BB, Chen JF, Cunha RA,
Svenningsson P and Vaugeois JM: Adenosine and brain function. Int
Rev Neurobiol. 63:191–270. 2005.PubMed/NCBI
|
|
43
|
Liu YJ, Chen J, Li X, Zhou X, Hu YM, Chu
SF, Peng Y and Chen NH: Research progress on adenosine in central
nervous system diseases. CNS Neurosci Ther. 25:899–910.
2019.PubMed/NCBI
|
|
44
|
Boison D, Chen JF and Fredholm BB:
Adenosine signaling and function in glial cells. Cell Death Differ.
17:1071–1082. 2020.
|
|
45
|
Boison D: Adenosine as a modulator of
brain activity. Drug News Perspect. 20:607–611. 2007.PubMed/NCBI
|
|
46
|
Huicong K, Zheng X, Furong W, Zhouping T,
Feng X, Qi H, Xiaoyan L, Xiaojiang H, Na Z, Ke X, et al: The
imbalanced expression of adenosine receptors in an epilepsy model
corrected using targeted mesenchymal stem cell transplantation. Mol
Neurobiol. 48:921–930. 2013.PubMed/NCBI
|
|
47
|
Jiang W, Van Cleemput J, Sheerin AH, Ji
SP, Zhang Y, Saucier DM, Corcoran ME and Zhang X: Involvement of
extracellular regulated kinase and p38 kinase in hippocampal
seizure tolerance. J Neurosci Res. 81:581–588. 2005.PubMed/NCBI
|
|
48
|
Cieślak M, Wojtczak A and Komoszyński M:
Role of the purinergic signaling in epilepsy. Pharmacol Rep.
69:130–138. 2017.PubMed/NCBI
|
|
49
|
Kim DS, Min SJ, Kim MJ, Kim JE and Kang
TC: Leptomycin B ameliorates vasogenic edema formation induced by
status epilepticus via inhibiting p38 MAPK/VEGF pathway. Brain Res.
1651:27–35. 2016.PubMed/NCBI
|
|
50
|
Akhtar S, Yousif MH, Chandrasekhar B and
Benter IF: Activation of EGFR/ERBB2 via pathways involving ERK1/2,
P38 MAPK, AKT and FOXO enhances recovery of diabetic hearts from
ischemia-reperfusion injury. PLoS One. 7:e390662012.PubMed/NCBI
|
|
51
|
Zhang YN, Dong HT, Yang FB, Wang ZQ, Ma
ZH, Ma SZ, Ma XD and Duan L: Nrf2-ARE signaling pathway regulates
the expressions of A1R and ENT1 in the brain of epileptic rats. Eur
Rev Med Pharmacol Sci. 22:6896–6904. 2018.PubMed/NCBI
|
|
52
|
Boison D: Adenosine as a neuromodulator in
neurological diseases. Curr Opin Pharmacol. 8:2–7. 2008.PubMed/NCBI
|
|
53
|
Zhang J, Visser F, King KM, Baldwin SA,
Young JD and Cass CE: The role of nucleoside transporters in cancer
chemotherapy with nucleoside drugs. Cancer Metastasis Rev.
26:85–110. 2007.PubMed/NCBI
|
|
54
|
Parkinson FE, Damaraju VL, Graham K, Yao
SY, Baldwin SA, Cass CE and Young JD: Molecular biology of
nucleoside transporters and their distributions and functions in
the brain. Curr Top Med Chem. 11:948–972. 2011.PubMed/NCBI
|
|
55
|
Rombo DM, Dias RB, Duarte ST, Ribeiro JA,
Lamsa KP and Sebastião AM: Adenosine A1 receptor suppresses tonic
GABAA receptor currents in hippocampal pyramidal cells and in a
defined subpopulation of interneurons. Cereb Cortex. 26:1081–1095.
2016.PubMed/NCBI
|
